VR Logo

Unrated

UTI Healthcare Fund - Regular Plan download report


1 Lakh

Investment Grown to
₹ 1.82 Lakh

₹ 10000

Monthly SIP Grown to
₹ 4.50 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
UTI Healthcare Reg-G -14.12 1.04 0.48 -8.45 -6.29 -11.63 -7.51 22.17 10.95 6.42 13.65
S&P BSE Healthcare TRI -13.37 1.32 1.10 -8.98 -5.75 -11.06 -5.43 20.58 9.27 5.25 13.81
Equity: Sectoral-Pharma -12.92 1.20 0.95 -8.49 -5.42 -10.30 -5.09 23.75 11.95 7.74 15.34
Rank within category 12 12 11 7 13 14 9 7 3 2 3
Number of funds in category 14 14 14 14 14 14 9 8 4 3 3

As on 17-May-2022

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
UTI Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jun-99 -7.51 22.17 10.95 2.30% 766
Nippon India Pharma Fund
Unrated
Jun-04 -5.44 24.25 15.75 1.78% 4,851
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 -6.73 23.90 -- 2.36% 2,392
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 -1.08 27.49 -- 2.05% 1,790
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 -7.27 22.39 9.55 2.21% 1,763

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 21.24 01-Apr-2020 - 09-Apr-2020 -16.12 15-Jan-2008 - 22-Jan-2008
Month 34.24 23-Mar-2020 - 22-Apr-2020 -31.35 09-May-2006 - 08-Jun-2006
Quarter 44.96 23-Mar-2020 - 22-Jun-2020 -27.70 02-Sep-2008 - 03-Dec-2008
Year 99.77 25-Mar-2009 - 25-Mar-2010 -26.83 31-Dec-2007 - 30-Dec-2008

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
UTI Healthcare Reg-G 21.72 20.90 0.87 1.86 0.92 2.35
S&P BSE Healthcare TRI 20.70 22.26 0.77 1.54 -- --
Equity: Sectoral-Pharma 23.23 20.13 0.98 2.02 0.88 4.59
Rank within category 7 6 8 6 6 8
Number of funds in category 8 8 8 8 8 8

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 30-Apr-2022

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 31
Top 10 Stocks (%) 57.11
Top 5 Stocks (%) 36.77
Top 3 Sectors (%) 98.34
Portfolio P/B Ratio 4.25
Portfolio P/E Ratio 28.90

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 35,171 58,227
Giant (%) 11.04 19.29
Large (%) 29.24 37.16
Mid (%) 48.79 37.19
Small (%) 10.33 6.71
Tiny (%) 0.61 0.73

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Sun Pharmaceutical Industries Healthcare 33.21 12.72 6.63 10.71
up Dr. Reddy's Lab Healthcare 24.67 11.67 4.87 7.99
down Cipla Healthcare 30.17 10.43 6.23 7.85
down Divi's Laboratories Healthcare 44.37 9.85 4.66 5.25
down Fortis Healthcare Healthcare 34.28 5.69 0.00 4.97
down Aurobindo Pharma Healthcare 10.93 9.55 2.36 4.84
down Krishna Institute Of Medical Sciences Healthcare 49.95 4.47 0.00 4.14
down Lupin Healthcare -- 9.27 1.99 3.96
equal Ipca Laboratories Healthcare 27.31 7.79 2.45 3.70
up Biocon Healthcare 61.41 6.05 0.00 3.70
equal Apollo Hospitals Healthcare 48.37 4.14 0.00 3.24
equal Ajanta Pharma Healthcare 20.35 5.58 2.48 2.96
equal Alembic Pharmaceuticals Healthcare 26.94 2.87 0.00 2.87
down Zydus Lifesciences Healthcare 7.49 6.33 2.26 2.84
down Eris Lifesciences Healthcare 23.45 5.68 1.90 2.73
down Suven Pharmaceuticals Healthcare 29.02 2.62 0.00 2.46
up Gland Pharma Healthcare 43.09 3.31 0.00 2.33
equal Narayana Hrudayalaya Healthcare 40.51 4.36 0.00 1.96
equal Metropolis Healthcare Healthcare 42.03 1.95 0.65 1.95
down JB Chemicals & Pharma Healthcare 30.95 3.97 0.00 1.93
up Alkem Laboratories Healthcare 21.14 2.93 0.00 1.91
equal Torrent Pharmaceuticals Healthcare 36.13 3.61 0.99 1.71
equal Poly Medicure Healthcare 51.31 1.83 0.00 1.70
up Pfizer Healthcare 33.05 4.86 0.00 1.64
down Ami Organics Healthcare 49.12 2.40 0.00 1.60

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 30-Apr-2022

Fund Manager

— Kamal Gada since 02-May-2022

Education: Mr. Gada is B.com, CA, CS, & CFA

Experience: Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.

— V Srivatsa since 02-Mar-2017

Education: Mr. Srivatsa is a B.Com (H), Chartered Accountant, CWA. and PGDM from IIM Indore.

Experience: Prior to joining UTI in 2002 he has worked with Ford, Rhodes Parks & Co., Chartered Accountants and Madras Cements Ltd.

Funds Managed:


1.04%

Change from previous, NAV as on 17-May-2022

Growth: ₹ 145.4586

IDCW: ₹ 112.4191


Investment Strategy

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Investment Details

Min. Investment (₹) 5,000
Min. Addl Investment (₹) 1,000
Min. SIP Investment (₹) 500
Min. No of Cheques 6
Min. Withdrawal (₹) --
Min. Balance (₹) 5,000
Lock-in Period Not Applicable
Exit Load 1% for redemption within 30 days

Basic Details

Fund House: UTI Mutual Fund
Launch Date: 28-Jun-1999
Return Since Launch: 13.76%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 766 Cr (As on 30-Apr-2022)
Expense: 2.30% (As on 31-Mar-2022)
Risk Grade: --
Return Grade: --
Turnover: 44.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW28-Oct-20101.7000

 26-Aug-20081.5000
 10-Jan-20062.5000
 10-Nov-20042.5000
 21-Nov-20032.0000

Contact Information

AMC: UTI Asset Management Company Ltd

Address: 1st Floor, Signature, Office No.103 Valsad Dharampur Road Mumbai - 396001

Phone: 0263 2296993

Fax: (0260) 2421315

Website: http://www.utimf.com

Registrar & Transfer Agent: KFin Technologies Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Investors' Hangout

Investment plan for retirees

DateFriday, 20-May-2022
Time12:30 PM - 12:40 PM

attending You have reserved a spot